Abstract
Abstract
Background
In Japan, there has been no investigation of regional differences in the number or amount of prescriptions of anxiolytics or hypnotics. Attributes related to the high amount of prescriptions for these drugs are unknown. We investigated recent trends and regional differences in the amount of prescriptions of hypnotics and anxiolytics in Japan and identified factors associated with these regional differences.
Methods
The National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open data from 2015 to 2018 were used. We calculated diazepam-equivalent doses (mg) for each drug and the total amount of prescriptions per capita for hypnotics and anxiolytics by sex and age. In addition, we calculated the standardized claim ratio (SCR) of the amount of prescriptions by prefecture. We investigated factors associated with regional differences in the SCRs of hypnotics and anxiolytics using the prefectures’ medical, socioeconomic, and physical characteristics by an ecological study using a linear mixed-effects model.
Results
The amount of prescriptions of hypnotics and anxiolytics, specifically, the amount of prescriptions of benzodiazepine receptor agonists (BZRAs), decreased in many of the adult age groups from 2015 to 2018. The regression analysis revealed that the number of medical clinics per capita, the number of public assistance recipients per capita, the proportion of persons whose HbA1c ≥ 6.5%, and the proportion of persons whose BMI ≥25 kg/m2 were positively and significantly associated with the SCR of hypnosis. In contrast, the number of public assistance recipients per capita and the proportion of persons whose BMI ≥25 kg/m2 were positively and significantly associated with the SCR of anxiolytics.
Conclusions
Factors associated with prescription amount of hypnotics and anxiolytics were revealed in this study, and a further study is needed for investigating causal relationships between the prescriptions amount and the associated factors using individual data.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference44 articles.
1. Ministry of Health, Labour and Welfare. Medical fee revision. https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000106602.html. Accessed 1 Aug 2021. (in Japanese).
2. Murasaki M. Current status and prospects of psychotropic drugs in Japan –aiming fror 21th century. Jpn J Clin Psychopharmacol. 2001;4:3–27 (in Japanese).
3. Chen TY, Winkelman JW, Mao WC, Tzeng NS, Kuo TBJ, Yang CCH, et al. Real-world evidence on the use of benzodiazepine receptor agonists and the risk of venous thromboembolism. J Thromb Haemost. 2020 Nov;18(11):2878–88.
4. Lee JY, Farrell B, Holbrook AM. Deprescribing benzodiazepine receptor agonists taken for insomnia: a review and key messages from practice guidelines. Pol Arch Intern Med. 2019 Jan 31;129(1):43–9.
5. Hirano Y, Ii Y. Changes in prescription of psychotropic drugs after introduction of Polypharmacy reduction policy in Japan based on a large-scale claims database. Clin Drug Investig. 2019 Nov;39(11):1077–92.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献